Gland Pharma Limited (NSE: GLAND) reported Revenue from Operations of ₹938.28 Crore down from ₹1,063.32 Crore year on year, a decline of 11.8%. Consolidated Net Profit of ₹231.94 Crore, slumped 15% from ₹273 Crore in the same quarter of the previous year. The Earnings per Share is ₹14.08 for this quarter.
Gland Pharma Limited Q3 FY23; Net Profit Down To 232 Crore
Related Post
- Firstsource Solutions Q2 FY26 Earnings Results
Firstsource Solutions Ltd, a leading player in Business Process Management (BPM) and part of the…
-
Foseco India Q2 FY26 Earnings Results
Foseco India Ltd, incorporated in 1958 and engaged in manufacturing metallurgical additives and consumables that…
-
Force Motors Q2 FY26 Earnings Results
Force Motors Ltd, founded in 1958 and part of the Abhay Firodia Group, specializes in…